The goal of the trial was to evaluate treatment with the acyl coenzyme A: cholesterol acyltransferase inhibitor (ACAT) pactimibe compared with placebo in patients with familial hypercholesterolemia.

A study carried out at Mount Sinaí Fuster Heart Hospital in New York in collaboration with the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid provides important new information ...

The progression of atherosclerosis in people who have no symptoms of it is independently associated with the risk of dying from any cause, according to a new study led by researchers from Mount Sinai ...